CompletedNot Applicable

Different Microlenses Array for Controlling Myopia Progression in Children and Adolescents

China134 participantsStarted 2024-08-01

Plain-language summary

This study aims to evaluate the effectiveness of lenses with different defocused microlens array in controlling the progression of myopia in children and adolescents, and to explore the feasibility of effective defocus microlens design, and apply personalized defocus frame lenses for myopia prevention and control.

Who can participate

Age range6 Years – 14 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Age: 6-14 years old;
✓. After using 1% cyclohexanone hydrochloride eye drops (Saifeijie) for ciliary muscle paralysis, binocular spherical power were within -0.50D\~-4.00D, binocular cylinder power ≤ 1.50D, the anisometropia is less than 1.50D, and the best corrected visual acuity was above 5.0;
✓. Within 30 days, the myopia prevention and control methods such as multifocal glasses, orthokeratology, defocusing flexible glasses, progressive glasses, atropine eye drops, red light and acupuncture and moxibustion treatment were not used;
✓. The subject has a willingness to receive treatment and an informed consent form is signed by their legal guardian.

Exclusion criteria

✕. Diagnosed constant strabismus;
✕. Diagnosed pathological myopia;
✕. Other congenital eye diseases;
✕. Researchers believe that the patients have other reasons that are not suitable for inclusion in the project.

What they're measuring

Subjective refraction equivalent spherical

Timeframe: 2 years

Trial details

NCT IDNCT06926556

SponsorShanghai Eye Disease Prevention and Treatment Center

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-10-31

View on ClinicalTrials.gov More Myopia Progressing trials